The global pharmaceutical supply chain for Loperamide, a widely used over-the-counter (OTC) antidiarrheal agent, represents a significant and expanding market. Valued at approximately USD 3.52 billion in 2025, it is projected to exceed USD 5.21 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.75%. For procurement managers, pharmaceutical distributors, and contract manufacturers, understanding the Loperamide Global Buyers List is essential for strategic sourcing and market expansion. This guide provides a comprehensive resource for navigating the complex landscape of global loperamide trade, detailing key buyers across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, and offering valuable insights into regulatory and compliance frameworks. Why a Loperamide Global Buyers List is…